Koers Prelude Therapeutics Incorporated
Aandelen
PRLD
US74065P1012
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,87 USD | +0,52% | -7,42% | -9,37% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 212 mln. 198 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -140 mln. -131 mln. | Nettowinst (verlies) 2025 * | -159 mln. -148 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 207 mln. 194 mln. | Nettoliquiditeiten 2025 * | 161 mln. 150 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,9
x | K/w-verhouding 2025 * |
-2,04
x | Werknemers | 128 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 93,07% |
Recentste transcriptie over Prelude Therapeutics Incorporated
1 dag | +0,52% | ||
1 week | -7,42% | ||
Lopende maand | -18,35% | ||
1 maand | -16,05% | ||
3 maanden | +25,65% | ||
6 maanden | +83,41% | ||
Lopend jaar | -9,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Krishna Vaddi
FOU | Founder | 58 | 01-02-16 |
Bryant Lim
DFI | Director of Finance/CFO | 53 | 01-02-23 |
Jane Huang
PSD | President | 51 | 04-04-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 25-01-21 |
Paul Friedman
CHM | Chairman | 81 | 01-07-16 |
David Bonita
BRD | Director/Board Member | 48 | 01-07-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 3,85 | +3,49% | 50 051 |
19-04-24 | 3,72 | +8,14% | 57 910 |
18-04-24 | 3,44 | -17,70% | 112 889 |
17-04-24 | 4,18 | -14,87% | 68 937 |
16-04-24 | 4,91 | -12,79% | 38 381 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,37% | 211 mln. | |
+3,13% | 42,11 mld. | |
+48,83% | 40,08 mld. | |
+8,49% | 40 mld. | |
-10,82% | 26,87 mld. | |
+8,26% | 24,58 mld. | |
-23,69% | 18,44 mld. | |
+1,58% | 11,94 mld. | |
+32,83% | 11,66 mld. | |
+6,63% | 11,01 mld. |